Blepharitis surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (19 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Blepharitis}} | {{Blepharitis}} | ||
{{CMG}} {{AE}} {{SaraM}} | {{CMG}}; {{AE}} {{SaraM}} | ||
==Overview== | ==Overview== | ||
[[Surgical|Surgical intervention]] is not the first-line treatment option for patients with blepharitis. | [[Surgical|Surgical intervention]] is not the first-line treatment option for patients with blepharitis. Surgery is usually reserved for patients with complications, such as [[chalazion]], [[entropion]], [[ectropion]], or horizontal eyelid laxity.<ref name="pmid24043929">{{cite journal| author=Qiao J, Yan X| title=Emerging treatment options for meibomian gland dysfunction. | journal=Clin Ophthalmol | year= 2013 | volume= 7 | issue= | pages= 1797-803 | pmid=24043929 | doi=10.2147/OPTH.S33182 | pmc=3772773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24043929 }} </ref><ref name="pmid21450919">{{cite journal| author=Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al.| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 2050-64 | pmid=21450919 | doi=10.1167/iovs.10-6997g | pmc=3072163 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450919 }} </ref> | ||
==Surgery== | ==Surgery== | ||
Surgery is not the firstline treatment option for patients with blepharitis. Surgery is usually reserved for patients with complications, such as [[chalazion]], [[entropion]], [[ectropion]], or horizontal eyelid laxity.<ref name="pmid24043929">{{cite journal| author=Qiao J, Yan X| title=Emerging treatment options for meibomian gland dysfunction. | journal=Clin Ophthalmol | year= 2013 | volume= 7 | issue= | pages= 1797-803 | pmid=24043929 | doi=10.2147/OPTH.S33182 | pmc=3772773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24043929 }} </ref><ref name="pmid21450919">{{cite journal| author=Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al.| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 2050-64 | pmid=21450919 | doi=10.1167/iovs.10-6997g | pmc=3072163 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450919 }} </ref> | |||
===Intraductal Meibomian Gland Probing=== | |||
Invasive orifice penetration and intraductal probing is usually reserved for patients with severe posterior blepharitis and [[meibomian gland]] dysfunction.<ref name="pmid20622668">{{cite journal| author=Maskin SL| title=Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. | journal=Cornea | year= 2010 | volume= 29 | issue= 10 | pages= 1145-52 | pmid=20622668 | doi=10.1097/ICO.0b013e3181d836f3 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20622668 }} </ref> | |||
===Thermal Pulsation=== | |||
Thermal pulsation (LipiFlow) is performed by simultaneously applying heat and pressure on the eyelids to express the meimobian glands. Unlike the traditional approaches (e.g., warm compresses, lid massage, and manual expression), thermal pulsation is associated with minimal heat transfer and direct expression pressure to the eyeball. A recent study on thermal pulsation demonstrated significant improvement in signs and symptoms of meibomian gland dysfunction.<ref name="pmid22222996">{{cite journal| author=Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR et al.| title=A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. | journal=Cornea | year= 2012 | volume= 31 | issue= 4 | pages= 396-404 | pmid=22222996 | doi=10.1097/ICO.0b013e318239aaea | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22222996 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
Latest revision as of 20:38, 29 July 2020
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis surgery On the Web | |
|
American Roentgen Ray Society Images of Blepharitis surgery | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Surgical intervention is not the first-line treatment option for patients with blepharitis. Surgery is usually reserved for patients with complications, such as chalazion, entropion, ectropion, or horizontal eyelid laxity.[1][2]
Surgery
Surgery is not the firstline treatment option for patients with blepharitis. Surgery is usually reserved for patients with complications, such as chalazion, entropion, ectropion, or horizontal eyelid laxity.[1][2]
Intraductal Meibomian Gland Probing
Invasive orifice penetration and intraductal probing is usually reserved for patients with severe posterior blepharitis and meibomian gland dysfunction.[3]
Thermal Pulsation
Thermal pulsation (LipiFlow) is performed by simultaneously applying heat and pressure on the eyelids to express the meimobian glands. Unlike the traditional approaches (e.g., warm compresses, lid massage, and manual expression), thermal pulsation is associated with minimal heat transfer and direct expression pressure to the eyeball. A recent study on thermal pulsation demonstrated significant improvement in signs and symptoms of meibomian gland dysfunction.[4]
References
- ↑ 1.0 1.1 Qiao J, Yan X (2013). "Emerging treatment options for meibomian gland dysfunction". Clin Ophthalmol. 7: 1797–803. doi:10.2147/OPTH.S33182. PMC 3772773. PMID 24043929.
- ↑ 2.0 2.1 Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T; et al. (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction". Invest Ophthalmol Vis Sci. 52 (4): 2050–64. doi:10.1167/iovs.10-6997g. PMC 3072163. PMID 21450919.
- ↑ Maskin SL (2010). "Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction". Cornea. 29 (10): 1145–52. doi:10.1097/ICO.0b013e3181d836f3. PMID 20622668.
- ↑ Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR; et al. (2012). "A new system, the LipiFlow, for the treatment of meibomian gland dysfunction". Cornea. 31 (4): 396–404. doi:10.1097/ICO.0b013e318239aaea. PMID 22222996.